Abstract
In situ gelling syringeable periodontal sol capable of dual controlled delivery of metronidazole benzoate and serratiopeptidase was designed based on 23 factorial design with drug, poloxamer 407 and aerosil as independent variables and sol gel transition characteristics, %CDR48h and palatability as responses. The sols had agreeable taste, were mucoadhesive, syringeable and inverted into gels at periodontal cavity temperature. F8 with optimal drug release was identified as the best formulation. The dispersion characteristics of poloxamer significantly affected the pharmacotechnical properties of the in situ gelling systems. Extra design checkpoint generated using Design Expert software 8.02 (Stat-Ease, USA) validated the experimental design. Thus a thermoreversible, in situ gelling and syringeable periodontal sol with acceptable taste characteristics that offered controlled release of metronidazole benzoate and serratiopeptidase was developed for application into the periodontal pocket. The developed optimized sol was satisfactory in terms of taste, syringeability, palatability and incorporation of serratiopeptidase as anti-inflammatory agent, has the potential of developing a therapeutically efficacious system for treatment of periodontal inflammatory anaerobic infections.
Keywords: 23factorial design, metronidazole benzoate, poloxamer 407, serratiopeptidase, aerosil, thermoreversible gel, periodontal, palatability, Design Expert 8.0.2, biphasic release
Current Drug Delivery
Title: Dual Controlled Release, In Situ Gelling Periodontal Sol of Metronidazole Benzoate and Serratiopeptidase: Statistical Optimization and Mechanistic Evaluation
Volume: 9 Issue: 1
Author(s): Neeraj Kumari and Kamla Pathak
Affiliation:
Keywords: 23factorial design, metronidazole benzoate, poloxamer 407, serratiopeptidase, aerosil, thermoreversible gel, periodontal, palatability, Design Expert 8.0.2, biphasic release
Abstract: In situ gelling syringeable periodontal sol capable of dual controlled delivery of metronidazole benzoate and serratiopeptidase was designed based on 23 factorial design with drug, poloxamer 407 and aerosil as independent variables and sol gel transition characteristics, %CDR48h and palatability as responses. The sols had agreeable taste, were mucoadhesive, syringeable and inverted into gels at periodontal cavity temperature. F8 with optimal drug release was identified as the best formulation. The dispersion characteristics of poloxamer significantly affected the pharmacotechnical properties of the in situ gelling systems. Extra design checkpoint generated using Design Expert software 8.02 (Stat-Ease, USA) validated the experimental design. Thus a thermoreversible, in situ gelling and syringeable periodontal sol with acceptable taste characteristics that offered controlled release of metronidazole benzoate and serratiopeptidase was developed for application into the periodontal pocket. The developed optimized sol was satisfactory in terms of taste, syringeability, palatability and incorporation of serratiopeptidase as anti-inflammatory agent, has the potential of developing a therapeutically efficacious system for treatment of periodontal inflammatory anaerobic infections.
Export Options
About this article
Cite this article as:
Kumari Neeraj and Pathak Kamla, Dual Controlled Release, In Situ Gelling Periodontal Sol of Metronidazole Benzoate and Serratiopeptidase: Statistical Optimization and Mechanistic Evaluation, Current Drug Delivery 2012; 9 (1) . https://dx.doi.org/10.2174/156720112798375998
DOI https://dx.doi.org/10.2174/156720112798375998 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
Call for Papers in Thematic Issues
Advances of natural products, bio-actives and novel drug delivery system against emerging viral infections
Due to the increasing prevalence of viral infections and the ability of these human pathogens to develop resistance to current treatment strategies, there is a great need to find and develop new compounds to combat them. These molecules must have low toxicity, specific activity and high bioavailability. The most suitable ...read more
Electrospun Fibers as Drug Delivery Systems
In recent years, electrospun fibers have attracted considerable attention as potential platforms for drug delivery due to their distinctive properties and adaptability. These fibers feature a notable surface area-to-volume ratio and can be intentionally designed with high porosity, facilitating an increased capacity for drug loading and rendering them suitable for ...read more
Emerging Nanotherapeutics for Mitigation of Neurodegenerative Disorders
Conditions affecting the central nervous system (CNS) present a significant hurdle due to limited access of both treatments and diagnostic tools for the brain. The blood-brain barrier (BBB) acts as a barrier, restricting the passage of molecules from the bloodstream into the brain. The most formidable challenge facing scientists is ...read more
Nanotechnology Based Chemotherapy for the treatment of Head & Neck Cancer
The escalating recurrence rates observed in Head and Neck cancer, particularly within the chemo-therapeutically treated cohort (50-60%), can be attributed to the non-selective nature of current anticancer drug delivery modalities. In this context, nanotechnology-based drug delivery systems emerge as a promising avenue for achieving precise localization of therapeutic agents to ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Odontogenic Infections in the Etiology of Infective Endocarditis
Cardiovascular & Hematological Disorders-Drug Targets Potential Therapeutic Properties of Natural Products Through the Expression of Heme Oxygenase-1
Mini-Reviews in Organic Chemistry Fabrication and Characterization of Polysorbate/Ironmolybdophosphate Nanocomposite: Ion Exchange Properties and pH-responsive Drug Carrier System for Methylcobalamin
Current Analytical Chemistry Editorial (Thematic Issue: Special Issue in Memory of Prof. Dr. Luis Eduardo Diaz: Current Topics in Pharmaceutical Biotechnology)
Current Pharmaceutical Biotechnology Biomarkers for Radiographic Progression in Rheumatoid Arthritis
Current Pharmaceutical Design Micro Composite Palmitoylethanolamide/Rutin Reduces Vascular Injury through Modulation of the Nrf2/HO−1 and NF-kB Pathways
Current Medicinal Chemistry The Importance of Drug Delivery to Optimize the Effects of Bone Morphogenetic Proteins During Periodontal Regeneration
Current Pharmaceutical Biotechnology Modulation of Matrix Metalloproteinases by Plant-derived Products
Current Cancer Drug Targets Chitosan Applications on Pharmaceutical Sciences: A Review
Drug Delivery Letters Contribution of Antimicrobial Peptides to the Development of New and Efficient Antimicrobial Strategies
Current Proteomics Periodontal Disease and Periodontal Tissue Regeneration
Current Stem Cell Research & Therapy Antimicrobial Host Defence Peptides of Human Neutrophils – Roles in Innate Immunity
Anti-Infective Agents in Medicinal Chemistry The Use of Nitric Oxide Synthase Inhibitors in Inflammatory Diseases: A Novel Class of Anti-Inflammatory Agents
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Preparation and Properties of Photosensitizer Loaded Magnetic Nanocarriers
Current Nanoscience Editorial (Thematic Issue: Nanotechnology for Drug Delivery: Part I)
Current Pharmaceutical Design Prescription Opioid Abuse and its Potential Role in Gross Dental Decay
Current Drug Safety Preface
Current Drug Delivery <i>Uncaria tomentosa</i> (Willd. ex Schult.): Focus on Nutraceutical Aspects
Current Bioactive Compounds Formulation and Characterisation of Tetracycline-Containing Bioadhesive Polymer Networks Designed for the Treatment of Periodontal Disease
Current Drug Delivery Curcumin Conjugates and Metallocomplexes as Lead Compounds for Development of Anticancer Agents - A Short Review
Current Bioactive Compounds